Early changes in gene expression profiles in AML patients during induction chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Early changes in gene expression profiles in AML patients during induction chemotherapy ; volume:23 ; number:1 ; day:14 ; month:11 ; year:2022 ; pages:1-11 ; date:12.2022
BMC genomics ; 23, Heft 1 (14.11.2022), 1-11, 12.2022
- Creator
-
Jakobsen, Ingrid
Sundkvist, Max
Björn, Niclas
Gréen, Henrik
Lotfi, Kourosh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12864-022-08960-4
- URN
-
urn:nbn:de:101:1-2023012721153556402644
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jakobsen, Ingrid
- Sundkvist, Max
- Björn, Niclas
- Gréen, Henrik
- Lotfi, Kourosh
- SpringerLink (Online service)
Other Objects (12)
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML
Correction: Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia
Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience
"AML!
AML
AML
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML
Correction: Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia
Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience
"AML!
AML
AML
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy
Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML
Correction: Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients
Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia
Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience
"AML!
AML